Japanese-Style Intensive Medical Care Improves Prognosis for Acute Liver Failure and the Perioperative Management of Liver Transplantation

被引:22
作者
Inoue, K. [1 ]
Watanabe, T. [1 ]
Maruoka, N. [1 ]
Kuroki, Y. [1 ]
Takahashi, H. [1 ]
Yoshiba, M. [1 ]
机构
[1] Showa Univ, Fujigaoka Hosp, Div Gastroenterol, Aoba Ku, Yokohama, Kanagawa 2278501, Japan
关键词
FULMINANT HEPATIC-FAILURE; SURVIVAL; SUPPORT;
D O I
10.1016/j.transproceed.2010.09.073
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Japanese style of intensive medical care for acute liver failure has yielded high survival rates. The care system comprises artificial liver support (ALS) together with treatment for the underlying disease. Plasma exchange in combination with high-volume hemodiafiltration using an high performance membrane has become the standard ALS system. It is safe, efficiently removing more low and middle molecular weight toxic substances than other methods because of the large volumes of buffer (more than 200 L per session), resulting in recovery from coma in patients with severe fulminant hepatitis, a status comparable with the ahepatic state. This ALS is therefore an effective tool to sustain patients with fulminant hepatitis in a favorable condition until liver function recovers or liver transplantation becomes available. The accompanying treatment for underlying disease serves to limit the liver destruction that hampers regeneration. The treatment has remarkably improved the prognosis for patients with subacute types of fulminant hepatitis, which generally carry a less favorable prognosis than the acute type. This treatment system thus provides more time for physicians to assess the indications for liver transplantation as well as giving the patient a greater chance of undergoing transplantation.
引用
收藏
页码:4109 / 4112
页数:4
相关论文
共 8 条
[1]   Pathophysiology of brain edema in fulminant hepatic failure, revisited [J].
Blei, AT .
METABOLIC BRAIN DISEASE, 2001, 16 (1-2) :85-94
[2]   Artificial Liver Support System Using Large Buffer Volumes Removes Significant Glutamine and Is an Ideal Bridge to Liver Transplantation [J].
Inoue, K. ;
Kourin, A. ;
Watanabe, T. ;
Yamada, M. ;
Yoshiba, M. .
TRANSPLANTATION PROCEEDINGS, 2009, 41 (01) :259-261
[3]   Right-lobe live donor liver transplantation improves survival of patients with acute liver failure [J].
Liu, CL ;
Fan, ST ;
Lo, CM ;
Yong, BH ;
Fung, ASM ;
Wong, J .
BRITISH JOURNAL OF SURGERY, 2002, 89 (03) :317-322
[4]   Living donor liver transplantation: the historical and cultural basis of policy decisions and ongoing ethical questions [J].
Northup, PG ;
Berg, CL .
HEALTH POLICY, 2005, 72 (02) :175-185
[5]   Fulminant hepatic failure [J].
Sass, DA ;
Shakil, AO .
LIVER TRANSPLANTATION, 2005, 11 (06) :594-605
[6]  
Trey C, 1970, Prog Liver Dis, V3, P282
[7]  
Yoshiba M, 1996, ARTIF ORGANS, V20, P1169
[8]  
YOSHIBA M, 1998, J INFECT CHEMOTHER, V4, P41